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Abstract
Background: The importance of mutations in disease phenotype has been studied, with information available in
databases such as OMIM. However, it remains a research challenge for the possibility of clustering amino acid
residues based on an underlying interaction, such as co-evolution, to understand how mutations in these related
sites can lead to different disease phenotypes.
Results: This paper presents an integrative approach to identify groups of co-evolving residues, known as protein
sectors. By studying a protein family using multiple sequence alignments and statistical coupling analysis, we
attempted to determine if it is possible that these groups of residues could be related to disease phenotypes. After
the protein sectors were identified, disease-associated residues within these groups of amino acids were mapped
to a structure representing the protein family. In this study, we used the proposed pipeline to analyze two test
cases of spermine synthase and Rab GDP dissociation inhibitor.
Conclusions: The results suggest that there is a possible link between certain groups of co-evolving residues and
different disease phenotypes. The pipeline described in this work could also be used to study other protein
families associated with human diseases.
Background
The role of mutations in disease phenotypes is an
important focus for human genetics [1-3]. The identifi-
cation of mutations and their link to a disease has gen-
erated numerous data entries which should optimally be
accessible for ongoing research efforts. This has resulted
in the establishment of databases such as the Online
Mendelian Inheritance in Man (OMIM) [4], where it is
possible to access data regarding a gene or gene product
and browse through the information of how different
mutations are associated with reported phenotypes.
Even though this represents a valuable resource for clin-
ical and molecular studies, the challenge of determining
if differences in the phenotypes (severity, expansion of
symptoms) within a syndrome can be associated with
changes in specific groups of residues remains to be
fully resolved. However, recent approaches in the study
of proteins and their evolution have opened a door to
analyze proteins from a different view [5-9] and attempt
to associate reported clinical phenotypes to groups of
correlated residues.
The techniques such as statistical coupling analysis
(SCA) and direct coupling analysis (DCA) amongst
others [5-7,10] have approached the study of proteins by
focusing on the idea of residue co-evolution within the
protein super-family [6,8,11]. These residues, whose
interaction is not hindered by their spatial distribution,
are organized within groups that have a seemingly
underlying evolutionary relationship amongst them.
Such groups of residues have been termed protein sec-
tors and have been identified in protein super-families
that comprise various lineages [6,10]. These protein sec-
tors have been characterized as important to the protein
by either contributing to its biological identity or its
function [5,9].
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The statistical coupling analysis requires the use of a
large number of sequences as well as structural models
for a representative member of the protein family to be
analyzed [6,7]. Although some protein structures are
still not available, the advancement in crystallography
accessibility as well as sequencing technologies coupled
with increasing computational power and protein mod-
eling accuracy and efficiency, has made it possible to
obtain large sets of data in order to explore these
approaches in multiple protein families, including those
of clinical significance in humans [12-14].
Previous studies have focused on identifying co-evolving
residues, and therefore understanding how these corre-
lated amino acid units, and the mutations within these
regions, could affect the protein. The most common
approaches consist of biochemical assays that provide
experimental support to the link between correlated resi-
due units and measureable characteristics such as stability
or catalytic activity [6,11]. However, it is important to note
that most of these studies have focused primarily on the
analysis of regions with an associated function, such as
domains, thus concentrating only on a segment of the
totality of residues that comprise the proteins.
Although the study of specific regions provides valuable
information to further understand how changes in amino
acids can affect the overall function of the protein, the
exclusion of residues outside the defined region could
however lead to a possible loss of valuable information
regarding residue distribution in functional sectors. This is
of special importance in human genetic disorders, where
diseases have multiple phenotypes ranging in severity,
which can be associated with the location of a mutation
within the protein.
We propose an integrative approach that consists of
analyzing full-length sequence alignments from pro-
teins and the subsequent identification of protein sec-
tors using statistical coupling analysis [6]. The
identified sectors and known mutation data from
OMIM as well as other information resources were
then used to determine a possible link between the
location of an amino acid residue change and disease
phenotype. Our results based on test case proteins
known to be associated with X-linked intellectual dis-
abilities revealed that it might be possible to associate
disease variants to protein sectors.
Methods
As shown in Figure 1, the pipeline used in our work
consisted of three different stages: (1) dataset acquisi-
tion, multiple sequence alignment and curation; (2)
identification of protein sectors and mapping of disease-
causing mutations; and (3) association between protein
sectors and disease phenotypes.
Dataset acquisition
The first step was to obtain a reference protein sequence.
Selection of the sequence and its organism is determined
based on the type of dataset to be analyzed. The retrieval
of homologous sequences belonging to the protein family
to be analyzed was done using one iteration of PSI-
BLAST with a maximum number of target sequences set
to 1000. This allowed us to obtain multiple sequences
representing diverse evolutionary lineages. The motiva-
tion behind this was to enrich sequence diversity, thus
allowing for the possible identification of groups of con-
served co-evolving residues. Another reason to attempt
to identify various sequences was to diminish the possible
bias towards an organism that has overrepresentation of
entries in the database. The approach of protein sector
analysis may not be applied to disease genes with few
homologous sequences in the database. However, this is
not supposed to be a common situation with more and
more genomes being sequenced.
BlastClust [15] was subsequently used to reduce
sequence redundancy within the dataset. The parameters
used were: similarity threshold of 85% and 100% coverage.
This helped diminish the over-representation of highly
similar proteins with different entry numbers. Clustering
of sequences further reduces the number of partial
sequences that could cause alignment discordances due to
their limited size. Further manual curation of the
sequences was done in order to generate a high-quality
sequence dataset for the alignment. In our pipeline, we
implemented conditions to maintain dataset quality which
primarily consisted of elimination of low quality predicted
proteins and discarding of partial sequences.
Figure 1 Proposed pipeline for analyzing co-evolving residues
from protein families associated with human diseases. The flow
chart includes the alternative of using homology modeling or other
protein modeling methods if the 3D structure is not available. The
association of disease information with protein sectors is in a grey
shaded box because it is the end result of the analysis.
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Protein structure retrieval
Protein structure files for the reference sequences used
in the test cases were obtained from the Protein Data
Bank [16]. The entry numbers were obtained by running
a BLAST search with the reference sequence and setting
the PDB as the search database. Highest scoring
matches were then selected and downloaded from the
PDB website. The PDB file was used to map the multi-
ple sequence alignment to the residue positions defined
in the structure file. This information was required for
analyzing each site to identify residue co-evolution.
An alternative for proteins without a 3D structure is
the use of homology modeling. We generated such
homology structure files for our test sets by using the
freely available software such as CPHmodels 3.2 [17] or
the Swiss-Model server [18]. The resulting PDB files
could be used in the pipeline. This alternative requires
the use of a separate numbering file for the residues,
which can be included in the pipeline.
Multiple sequence alignment
Each of the working datasets was subsequently aligned
using ClustalW [19] incorporated in MEGA5 [20]. The
parameters were set as default for gap penalties and the
substitution matrix selected was BLOSUM62 [21]. After
alignment, manual adjustments were undertaken to
further curate the alignment file. These modifications
included the elimination of high gap-creating sequences
and trimming of large sequences (based on comparison
of starting and ending residues of the reference or “seed”
sequence). After this was accomplished, gaps were elimi-
nated and sequences were realigned using the same algo-
rithm and parameters. The final alignment files varied in
the number of sequences, but for each test case there
were more than 250 amino acid sequences in each file.
Protein sector identification
The statistical coupling analysis was undertaken to iden-
tify the groups of coevolving residues. The SCA toolbox
for MATLAB was obtained from the Rama Ranganathan
laboratory at the Green Center for Systems Biology, UT
Southwestern Medical Center. The MATLAB script was
modified and adapted to analyze the test cases.
The identification of protein sectors was accomplished
using the methodology previously described [6,11]. This
consists of the calculation of the degree of conservation
for each amino acid position. Subsequently, the statistical
coupling analysis generates a positional correlation and a
sequence correlation matrix. This was followed by a spec-
tral decomposition and analysis of the statistically signifi-
cant eigenvalues, and an independent component analysis,
which further defines the identified protein sectors. Finally,
the protein sectors are mapped onto the primary structure
of the protein based on their position in the structure file.
This information can also be used to generate a 3D struc-
ture with different protein sectors (For further information
refer to Halabi et al [6]).
Mapping of mutations within protein sectors
The information associated with mutations in a protein
family can be obtained from databases such as OMIM as
well as publications related to the protein family, their clini-
cal importance and reported phenotypes known to be asso-
ciated with the mutations. The clustering or grouping of
mutations can be based on their location, within one of the
major regions: N-terminal, central/other, and C-terminal.
This allows for the preliminary classification of the muta-
tions as well as the latter characterization of the residues
identified within the protein sectors.
The labeling and numbering of residues and their cor-
responding sectors was done using a PDB file obtained
by BLAST search using the reference sequence for each
family as a query. The full-length sequence was used to
maximize the number of possible residues belonging to
protein sectors. By increasing the length and coverage of
the alignment, it is possible to identify co-evolving resi-
dues outside the main protein domain, which could be
associated with a disease phenotype.
Visualization of sectors in the protein 3D structure
The program Jmol http://jmol.sourceforge.net/ was used
to visualize the 3D structures in PDB files. Protein
domains were subsequently identified and colored using
the information available from PDB. Each domain was
assigned an arbitrary color, based on visualization pur-
poses (not functional association). For the visualization
of protein sectors, the residues identified were assigned
the color that corresponded to the group of residues to
which they belonged based on the SCA analysis.
Results and discussion
Identification of protein sectors
The selection of spermine synthase (SMS) and the Rab
GDP dissociation inhibitor 1 (GDI1) as test cases was
based on the available information for both proteins.
SMS has been widely studied, with multiple mutations
and the associated phenotypes comprehensively
described as well as a vast amount of information on
the importance of this molecule in brain development
[22-25]. These characteristics as well as the fully
resolved crystal structure (PDB: 3C6K) made SMS a
good candidate as a test case.
GDI1 has been associated with non-specific X-linked
intellectual disability, with different mutations being
reported [26,27]. This represents an interesting study
case to determine if co-evolving residues could possibly
be associated with disorders that appear to have clinical
and genetic heterogeneity [26]. This protein also has an
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available crystal structure (PDB: 1LV0), which made it a
suitable test case to analyze with the proposed approach.
The test cases of SMS and GDI1 were analyzed using
full-length sequences and their corresponding structures.
The results reported in this paper were obtained using a
personal computer (Intel Core i7 Q720 at 1.60 GHz,
4.00 GB RAM) installed with the MATLAB 2012a and
SCA packages. The analysis covered 90% of the residues
represented in the crystal structures of SMS [28] and
GDI1 [29]. This allowed for further identification of sec-
tor-grouped residues, located across the covered area of
the protein. A possible issue is the need of protein
structural data for the analysis. Such data may not be
always available. However, this can be addressed using
methods such as homology or ab initio modeling. Since
the analysis of residue co-evolution is based on the mul-
tiple sequence alignment, the accuracy of homology
modeling does not represent an issue to the approach.
The structure model is only used to map the positions
of the multiple sequence alignment to the primary
structure of the protein. Thus, the modeled structure
file can be used in the pipeline in the same manner as
the files obtained from the Protein Data Bank.
The protein sector analysis of both SMS and GDI1
revealed the distribution of groups of co-evolving resi-
dues (Figure 2a and 2b) that present a degree of spatial
separation which differs from that found in protein
domains (Figure 3a and 3b). When analyzing the sectors
of SMS, we were able to identify three groups classified
as the red, blue and green sector. Our results indicated
that the red and blue sectors appear to be in the N-
terminal region and to some extent the long loop and
the beta strand domain (Figure 2a). However, the pre-
sence of residues of the red sector appears to be limited
to these three regions, whereas the blue and green sec-
tors span the C-terminal region, with no red sector resi-
dues identified in this region.
For GDI1, our analysis identified three distinct sectors,
red, blue and green. The FAD/NAD(P) binding domain,
located in the N-terminal region of GDI1, had amino
acid residues classified within the blue and green sector
(Figure 2b), with only three positions (82, 125 and 283)
identified as belonging to the red sector. When analyz-
ing the FAD-linked reductase and the FAD/NAD(P)
binding domain located in the central and C-terminal
regions of the protein, the residues in both are mostly
classified as being part of the red sector (Figure 2b),
with reduced presence of residues classified into the
green and blue sectors. Although sector distribution of
residues appears to follow a pattern where one group of
residues is predominant over the others in a specific
region, our analysis revealed that even within these
regions, residues belonging to different sectors were
identified (Figure 2a and 2b). This finding supports a
degree of differentiation between protein sectors and
domains.
Our results indicate that although protein sectors may
be distributed across the proteins, there is a concentra-
tion of these co-evolving residues in certain areas of the
proteins (Figure 2a and 2b), with stretches of residues
that were not identified to be part of any sector. This
observation could be attributed to the presence of con-
served catalytic centers or active sites, necessary for pro-
tein function. One example was residue 276 in SMS
(Table 1), which is a known active site that was not
assigned to any sector. For GDI1, residue 92 (Table 1)
has been reported to be necessary for the binding and
recycling of RAB3 [27], and mutations in this site could
lead to a reduction in its activity. This residue was also
not classified in any of the three identified sectors.
Because such important residues tend to be highly con-
served, it is possible that these sites are not prone to
undergo the co-evolutionary process.
Disease-associated residues in protein sectors
The protein sector analysis of our test cases revealed a
possible link between different disease phenotypes and
the locations of the mutations within groups of co-evol-
ving residues. We were able to identify multiple residues,
in which disease-causing mutations have been identified
(Table 1). As stated in Halabi et al. [6], groups of co-evol-
ving residues seem to be associated with specific func-
tions. In SMS, we identified the presence of a sector
within the N-terminal region, which is necessary for pro-
tein dimerization. It has been reported that the ability to
form dimers is necessary for full protein functionality. In
our analysis, we found that the most severe phenotypes
for the Snyder-Robinson Syndrome were predominantly
found in the red sector, with residues mapped not only
to the N-terminal region but also in the long loop and
beta-strand domains (Figure 2a and 3a).
The results suggest that protein sectors, when compared
to domains, allow for the clustering of mutations based on
the underlying process of residue co-evolution instead of
grouping them by sequential or spatial locations. The pro-
tein sector analysis of SMS has shown that the known
Snyder-Robinson syndrome phenotypes, including
expanded phenotypes [30], are mainly related to the red
sector (Table 1), which comprises the N-terminal region
as well as the long loop and beta strand domain. Thus, a
protein sector can be associated with diverse functions as
previously reported [6]. It appears that the red sector in
SMS comprises regions associated with both dimerization
and protein stability (Table 1), and these spatially distant
regions may have undergone the co-evolutionary process
because of their roles in the function of the protein. Inter-
estingly, another mutation in SMS has been mapped to
the green sector. This residue at position 328 (Table 1)
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has been associated with a milder form of the Snyder-
Robinson syndrome [31]. It is possible that the green sec-
tor in the C-terminal region comprises residues associated
with the enzyme’s substrate recognition [28]. This may
lead to a decrease in enzymatic activity, thus possibly
accounting for the milder form of the syndrome [28].
The analysis of GDI1 identified two known mutations
located in the green and blue sectors (Table 1). These
amino acid positions (70 and 423) are associated with
non-specific X-linked intellectual disability [26,27]. The
two residues are located in spatially separated regions,
with the residue at position 70 in the N-terminal FAD/
NAD(P)-binding domain and the residue at position 423
in the C-terminal region (Figure 2b). It is still unknown
whether these two mutations, distributed in different
sectors, may cause any difference in disease phenotypes.
Further studies are needed to explain our findings and
expand the knowledge about this protein, including the
possible role of the co-evolving resides in disease. The
third residue at position 92 has been proposed as an
important substrate binding site [26,27], and appears
not to be undergoing co-evolution, probably owing to
Figure 2 Identification of protein sectors in the primary structure of SMS and GDI1. A) Distribution of the protein sectors within the
different regions of human spermine synthase. The analyzed residues correspond from position 28 to 365 based on the structure (PDB: 3C6K).
The pattern observed appears to correspond to a stratification of sectors where the N-terminal region associated with dimerization appears to
dominate the red sector, whereas the C-terminal region, ranging from residues 173 to 366, is composed of the blue and green sectors. B)
Distribution of the protein sectors in Rab GDP dissociation inhibitor. The analyzed residues correspond from positions 1 to 447 based on the
PDB structure file (1LV0). The N-terminal FAD/NAD(P) binding domain appears to be predominantly composed of residues belonging to the
green and blue sectors. The FAD-linked reductase and the C-terminal FAD/NAD(P) binding domains appear to have a majority of residues
classified within the red sector with a small presence of amino acids belonging to the blue and green sectors.
Figure 3 Representation of protein domains and identified sectors in the 3D structure of spermine synthase (PDB: 3C6K). A) Protein
domains were colored in one of the chains of the homodimer. Red corresponds to the N-terminal domain, the long loop is in purple, the beta
strand domain is in yellow, and the C-terminal region is in blue, with the catalytic center shown in light blue. B) Identified protein sectors in
spermine synthase. Each sector is represented with a different color, and appears to have a distribution that is not limited to the described
domains.
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its significance in stabilizing the Rab-binding region or
recognition of the C-terminal prenyl group in substrate
recycling [27]. This may explain why our analysis did
not identify it in any of the three sectors.
Our results from the protein sector analysis of SMS
suggest a possible link between groups of co-evolving
residues and disease severity. However, to fully under-
stand the role of protein sectors, the use of mutagenic
analysis can provide further information. Experimental
validation of our results would present further evidence
to support the approach of clustering disease-associated
residues with their corresponding clinical manifestation.
In addition, although we have presented a pipeline use-
ful for clustering mutations, it is possible that other fac-
tors, such as the type of amino acid substitutions, could
be the underlying cause of the differences in disease
severity. Nevertheless, by clustering residues into differ-
ent sectors, our approach can be used as a valuable aid
in further characterizing the possible causes of disease
such as intellectual disability. Protein sector analysis
may also provide useful information for understanding
the effect of mutations at spatially distant positions on
disease phenotypes.
Conclusions
We have proposed an integrative approach that makes
use of the statistical coupling analysis method for the
study of disease-causing mutations in proteins. Our test
cases provided information regarding the role of protein
sectors and how they could be associated to disease var-
iants. We were also able to identify the effect of muta-
tions in distinct sectors with variations in the clinical
signs of a disease. These findings support the possible
role of the protein sectors in specific functions that
when affected could lead to variable phenotypes asso-
ciated with a complex syndrome.
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